• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶在病毒性和非病毒性慢性肝病中的差异表达

Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases.

作者信息

Ljumovic Dusanka, Diamantis Ioannis, Alegakis Athanasios K, Kouroumalis Elias A

机构信息

Liver Research Laboratory University of Crete Medical School, 71003 Heraklion, Crete, Greece.

出版信息

Clin Chim Acta. 2004 Nov;349(1-2):203-11. doi: 10.1016/j.cccn.2004.06.028.

DOI:10.1016/j.cccn.2004.06.028
PMID:15469875
Abstract

BACKGROUND

Fibrosis is a common consequence of chronic liver diseases irrespective of aetiology. Metalloproteinases play an important role in the fibrotic process participating in the balance between collagen synthesis and degradation. We examined whether matrix gelatinases and stromelysins are similarly involved in the development of viral (HCV, HBV) and non-viral (NASH) liver diseases.

METHODS

Hepatic mRNA levels of matrix metalloproteinase MMP-2, MMP-9, MMP-10 and MMP-11 isolated from liver biopsies were measured by semi-quantitative RT-PCR. Seventy-three patients were examined in this study: non-diseased controls (10), patients with chronic hepatitis B (14), chronic hepatitis C (33) and non-alcoholic steatohepatitis (16).

RESULTS

A significant increase of MMP-9 and MMP-10 expression was found in patients with non-viral (non-alcoholic steatohepatitis) liver disease. Patients with chronic hepatitis B and hepatitis C showed an increase in MMP-2 mRNA expression compared to controls. Moreover, chronic hepatitis B and hepatitis C patients had significantly different mRNA expression patterns.

CONCLUSIONS

These findings indicate that matrix metalloproteinases are differentially involved in the fibrotic process of viral and non-viral chronic liver diseases. Differences exist between HBV and HCV chronic hepatitis. Differences between early and late fibrosis indicate that in future studies, careful staging of patients is mandatory for interpretation of results.

摘要

背景

纤维化是慢性肝病常见的后果,与病因无关。金属蛋白酶在纤维化过程中发挥重要作用,参与胶原蛋白合成与降解的平衡。我们研究了基质明胶酶和基质溶素是否同样参与病毒性(丙型肝炎病毒、乙型肝炎病毒)和非病毒性(非酒精性脂肪性肝炎)肝病的发展。

方法

通过半定量逆转录聚合酶链反应测量从肝活检中分离出的基质金属蛋白酶MMP-2、MMP-9、MMP-10和MMP-11的肝脏mRNA水平。本研究共检查了73例患者:非患病对照者(10例)、慢性乙型肝炎患者(14例)、慢性丙型肝炎患者(33例)和非酒精性脂肪性肝炎患者(16例)。

结果

在非病毒性(非酒精性脂肪性肝炎)肝病患者中发现MMP-9和MMP-10表达显著增加。与对照相比,慢性乙型肝炎和丙型肝炎患者的MMP-2 mRNA表达增加。此外,慢性乙型肝炎和丙型肝炎患者的mRNA表达模式有显著差异。

结论

这些发现表明,基质金属蛋白酶以不同方式参与病毒性和非病毒性慢性肝病的纤维化过程。乙型肝炎病毒和丙型肝炎病毒慢性肝炎之间存在差异。早期和晚期纤维化之间的差异表明,在未来的研究中,为了解释结果,对患者进行仔细分期是必要的。

相似文献

1
Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases.基质金属蛋白酶在病毒性和非病毒性慢性肝病中的差异表达
Clin Chim Acta. 2004 Nov;349(1-2):203-11. doi: 10.1016/j.cccn.2004.06.028.
2
Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis.基质金属蛋白酶在慢性丙型肝炎及丙型肝炎病毒诱导的肝硬化中的表达及协同调控
Clin Sci (Lond). 2003 Sep;105(3):373-82. doi: 10.1042/CS20030098.
3
Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.基质金属蛋白酶(MMP)-1、MMP-3和MMP-9功能基因多态性与慢性肝病进展的关联
J Gastroenterol Hepatol. 2005 Jul;20(7):1102-8. doi: 10.1111/j.1440-1746.2005.03860.x.
4
Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.乙型肝炎病毒携带者慢性肝炎患者血浆基质金属蛋白酶(MMP)-9/MMP-2比值与甲胎蛋白水平的相关性
J Gastroenterol Hepatol. 2004 May;19(5):565-71. doi: 10.1111/j.1440-1746.2004.03344.x.
5
Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.肢体缺血患者骨骼肌中的基底膜重塑涉及基质金属蛋白酶和基质金属蛋白酶组织抑制剂的调节。
J Vasc Res. 2007;44(3):202-13. doi: 10.1159/000100376. Epub 2007 Feb 27.
6
[Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].子痫前期患者胎盘滋养细胞侵袭相关基因mRNA和蛋白的表达
Zhonghua Fu Chan Ke Za Zhi. 2006 Aug;41(8):509-13.
7
Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.肿瘤和基质来源的MT1-MMP表达与SCID小鼠中人卵巢肿瘤进展的相关性。
Gynecol Oncol. 2004 Dec;95(3):437-48. doi: 10.1016/j.ygyno.2004.08.032.
8
[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].[基质金属蛋白酶-9、2、7及金属蛋白酶组织抑制剂-1、2、3 mRNA在卵巢肿瘤中的表达及其临床意义]
Ai Zheng. 2004 Oct;23(10):1194-8.
9
Accumulation of extracellular matrix in the liver induces high metastatic potential of hepatocellular carcinoma to the lung.肝脏中细胞外基质的积累会诱导肝细胞癌向肺部转移的高潜能。
Int J Oncol. 2001 Jul;19(1):65-70.
10
Matrix metalloproteinase expression in the ascending aorta and aortic valve.升主动脉和主动脉瓣中基质金属蛋白酶的表达
Interact Cardiovasc Thorac Surg. 2008 Feb;7(1):37-40. doi: 10.1510/icvts.2007.163311. Epub 2007 Nov 19.

引用本文的文献

1
Quinoa Polyphenol Extract Alleviates Non-Alcoholic Fatty Liver Disease via Inhibiting Lipid Accumulation, Inflammation and Oxidative Stress.藜麦多酚提取物通过抑制脂质积累、炎症和氧化应激缓解非酒精性脂肪肝疾病。
Nutrients. 2024 Jul 15;16(14):2276. doi: 10.3390/nu16142276.
2
Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Metabolism: Insights into Health and Disease.基质金属蛋白酶及其天然抑制剂在代谢中的作用:健康与疾病的新视角。
Int J Mol Sci. 2023 Jun 26;24(13):10649. doi: 10.3390/ijms241310649.
3
Enzymes of Fibrosis in Chronic Liver Disease.
慢性肝病中的纤维化酶
Biomedicines. 2022 Dec 8;10(12):3179. doi: 10.3390/biomedicines10123179.
4
Administration of hydro-alcoholic extract of spinach improves oxidative stress and inflammation in high-fat diet-induced NAFLD rats.菠菜水醇提取物给药可改善高脂饮食诱导的非酒精性脂肪肝病大鼠的氧化应激和炎症。
BMC Complement Med Ther. 2021 Sep 3;21(1):221. doi: 10.1186/s12906-021-03396-x.
5
Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis.丙型肝炎病毒与细胞外基质在肝纤维化和早期癌变过程中的分子串扰
Cancers (Basel). 2021 May 9;13(9):2270. doi: 10.3390/cancers13092270.
6
Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis.糜酶作为改善非酒精性脂肪性肝炎的可能治疗靶点。
Int J Mol Sci. 2020 Oct 13;21(20):7543. doi: 10.3390/ijms21207543.
7
Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease.高果糖高脂肪饮食诱导的糖尿病相关非酒精性脂肪肝病中的病理生物学和分子联系。
Inflamm Res. 2020 Sep;69(9):851-867. doi: 10.1007/s00011-020-01373-7. Epub 2020 Jun 23.
8
High Fib4 index in patients with suspected NASH is associated with elevation of chymase-dependent angiotensin II-forming activity in circulating mononuclear leucocytes.疑似非酒精性脂肪性肝炎患者的高Fib4指数与循环单核白细胞中糜酶依赖性血管紧张素II生成活性升高有关。
Heart Vessels. 2019 Sep;34(9):1559-1569. doi: 10.1007/s00380-019-01391-4. Epub 2019 Mar 27.
9
Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis.糜蛋白酶抑制剂作为非酒精性脂肪性肝炎的新型治疗药物
Front Pharmacol. 2018 Feb 21;9:144. doi: 10.3389/fphar.2018.00144. eCollection 2018.
10
Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH.非酒精性脂肪性肝炎患者中 Vitronectin V10 亚单位的过表达:对 NASH 无创诊断的意义。
Int J Mol Sci. 2018 Feb 18;19(2):603. doi: 10.3390/ijms19020603.